Kaposi’s Sarcoma Associated with HIV Infection: a Case Report and Literatures review
Article Sidebar
Main Article Content
Abstract
Kaposi’s sarcoma (KS) is one of cancer that associated with HIV infection. Skin lesions are located in dermis and believe it from mesenchymal cell of endothelium origin. This report of a 39 year old homosexual male presented with fatigue and purplish macules scattered over skin for one month. He did not have any other systemic complaints. A year ago, he was reactive to HIV testing and not received antiretroviral treatment. Biopsy from skin lesion was confirmed the diagnosis of Kaposi’s sarcoma. The patient was started highly active anti-retroviral therapy (HAART). Three weeks after treatment, the skin lesions were regressed.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Kaposi M. Idiopathic Pigment. Arch Dermatol Syph 1872; 4: 256-73.
Chang Y, Cesarman E, Pessin M, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 1994; 266:1865-9.
Rabkin CS, Yellin F. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1.J Natl Cancer Inst 1994; 86:1711-6.
Jacobson LP, Munoz A, Fox R, Phair JP, Dudley J, Obrams GI, et al. Incidence of Kaposi’s sarcoma in a cohort of homosexual men infected with the human immunodeficiency virus type 1. The Multicenter AIDS Cohort Study Group. J Acquir Immune Defic Syndr 1990; 3: S24-S31.
Montaner JS, Le T, Hogg R, Ricketts M, Sutherland D, Strathdee SA, et al. The changing spectrum of AIDS index diseases in Canada. AIDS 1994; 8: 693-6.
Kaposi’s sarcoma and Pneumonia among homosexual men-New York City and California. MMWR Morb Mortal Wkly Rep 1981; 30: 305-8.
Barrison IG, Foster S, Harris JW, Pinching AJ, Walker JG. Upper gastrointestinal Kaposi’s sarcoma in patients positive for HIV antibody without cutaneous disease. Br Med J 1988; 296: 92-3.
Danzig JB, Brandt LJ, Reinus JF, Klein RS. Gastrointestinal malignancy in patients with AIDS. Am J Gastroenterol 1991; 86: 715-8.
Laine L, Amerian J, Rarick M, Harb M, Gill PS. The response of symptomatic gastrointestinal Kaposi’s sarcoma to chemotherapy: a propective evaluation using an endoscopic method of disease quantification. Am J Gastroenterol 1990; 85: 959-61.
Ioachim HL, Adsay V, Giancotti FR, Dorsett B, Melamed J. Kaposi’s sarcoma of internal organs. A Mutiparmeter study of 86 cases. Cancer 1995; 75: 1376-85.
White DA. Pulmonary complications of HIV-associated malignancies. Clin Chest Med 1996; 17: 755-61.
Garay SM. Pulmonary manifestations of Kaposi’s sarcoma. Chest 1987; 91: 39-43.
Flexner C. HIV-protease inhibitors. N Engl J Med 1998; 338: 1281-92.
Pallella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853-60.
Krown SE. Highly active antiretroviral therapy in AIDSassociated Kaposi’s sarcoma: Implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi’s sarcoma. J Clin Oncol 2004; 22: 399-402.
Mocroft A, Kirk O, Clumeck N, Gargalianos-Kakolyris P, Trocha H, Chentsova N, et al. The changing pattern of Kaposi Sarcoma in patients with HIV, 1994-2003: The EuroSIDA study. Cancer 2004; 100: 2644-54.
Von Roenn JH, Krown SE. Management of AIDS-associtated Kaposi’s sarcoma: a multidiscripinary perspective. Oncology 1998; 12: 317.